<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>rPPG Archives - HIT Leaders and News</title>
	<atom:link href="https://us.hitleaders.news/tag/rppg/feed/" rel="self" type="application/rss+xml" />
	<link>https://us.hitleaders.news/tag/rppg/</link>
	<description>Healthcare Innovations and technology news and views</description>
	<lastBuildDate>Tue, 15 Nov 2022 20:17:55 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>
	<item>
		<title>NuraLogix Researchers Announce the Capability to Assess Type 2 Diabetes and Blood Biomarker Health Issues Using Any Video-Enabled Device</title>
		<link>https://us.hitleaders.news/imaging/38579/nuralogix-researchers-announce-the-capability-to-assess-type-2-diabetes-and-blood-biomarker-health-issues-using-any-video-enabled-device/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=nuralogix-researchers-announce-the-capability-to-assess-type-2-diabetes-and-blood-biomarker-health-issues-using-any-video-enabled-device</link>
		
		<dc:creator><![CDATA[Jason Free]]></dc:creator>
		<pubDate>Mon, 14 Nov 2022 17:43:52 +0000</pubDate>
				<category><![CDATA[Imaging]]></category>
		<category><![CDATA[Anura]]></category>
		<category><![CDATA[NuraLogix]]></category>
		<category><![CDATA[Remote Photoplethysmography]]></category>
		<category><![CDATA[rPPG]]></category>
		<category><![CDATA[RSNA]]></category>
		<category><![CDATA[Transdermal Optical Imaging]]></category>
		<category><![CDATA[type 2 diabetes]]></category>
		<guid isPermaLink="false">https://us.hitleaders.news/?p=38579</guid>

					<description><![CDATA[<p>Researchers at NuraLogix, a provider of contactless health monitoring through its patented Transdermal Optical Imaging (TOI) technology, has announced that it is adding the ability to perform metabolic and blood biomarker health risk assessments for various chronic conditions to its Anura platform.  </p>
<p>The post <a href="https://us.hitleaders.news/imaging/38579/nuralogix-researchers-announce-the-capability-to-assess-type-2-diabetes-and-blood-biomarker-health-issues-using-any-video-enabled-device/">NuraLogix Researchers Announce the Capability to Assess Type 2 Diabetes and Blood Biomarker Health Issues Using Any Video-Enabled Device</a> appeared first on <a href="https://us.hitleaders.news">HIT Leaders and News</a>.</p>
]]></description>
		
		
		
			</item>
	</channel>
</rss>

<!--
Performance optimized by W3 Total Cache. Learn more: https://www.boldgrid.com/w3-total-cache/?utm_source=w3tc&utm_medium=footer_comment&utm_campaign=free_plugin

Page Caching using Disk: Enhanced 
Content Delivery Network Full Site Delivery via cloudflare

Served from: us.hitleaders.news @ 2026-04-23 20:24:25 by W3 Total Cache
-->